These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6103230)

  • 21. Food choice in people with Prader-Willi syndrome: quantity and relative preference.
    Joseph B; Egli M; Koppekin A; Thompson T
    Am J Ment Retard; 2002 Mar; 107(2):128-35. PubMed ID: 11853530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.
    Haqq AM; Stadler DD; Jackson RH; Rosenfeld RG; Purnell JQ; LaFranchi SH
    J Clin Endocrinol Metab; 2003 May; 88(5):2206-12. PubMed ID: 12727976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contaminated and unusual food combinations: what do people with Prader-Willi syndrome choose?
    Dykens EM
    Ment Retard; 2000 Apr; 38(2):163-71. PubMed ID: 10804706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of naloxone on selection of nutrients by bulimic women.
    Soll E; Thomas B; Mitchell JE; Morley J
    Am J Psychiatry; 1989 Jun; 146(6):803. PubMed ID: 2729436
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
    Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
    Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.
    Seetho IW; Jones G; Thomson GA; Fernando DJ
    Diabetes Res Clin Pract; 2011 Apr; 92(1):e1-2. PubMed ID: 21227526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Naltrexone/Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: "Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent" by Puri et al.
    Hor A; Purtell L
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):854. PubMed ID: 27768385
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lisdexamphetamine as a novel therapy for hyperphagia in Prader-Willi syndrome.
    Preddy J; Smith-Wade S; Houghton K
    J Paediatr Child Health; 2023 Mar; 59(3):570-572. PubMed ID: 36749028
    [No Abstract]   [Full Text] [Related]  

  • 32. [A teenager with Prader-Willi syndrome with loss of appetite].
    Smorenberg A; Buter NH; Mollema R; Toornvliet AC; Hack WW
    Ned Tijdschr Geneeskd; 2014; 158():A7503. PubMed ID: 25096033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial direct current stimulation: a novel approach to control hyperphagia in Prader-Willi syndrome.
    Boggio PS; de Macedo EC; Schwartzman JS; Brunoni D; Teixeira MC; Fregni F
    J Child Neurol; 2009 May; 24(5):642-3. PubMed ID: 19406762
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prader-Willi syndrome: clinical and molecular cytogenetic investigations.
    Hou JW; Wang TR
    J Formos Med Assoc; 1996 Jun; 95(6):474-9. PubMed ID: 8772055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prader-Willi syndrome as a model of human hyperphagia.
    Tauber M; Diene G; Mimoun E; Çabal-Berthoumieu S; Mantoulan C; Molinas C; Muscatelli F; Salles JP
    Front Horm Res; 2014; 42():93-106. PubMed ID: 24732928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome.
    Tauber M; Boulanouar K; Diene G; Çabal-Berthoumieu S; Ehlinger V; Fichaux-Bourin P; Molinas C; Faye S; Valette M; Pourrinet J; Cessans C; Viaux-Sauvelon S; Bascoul C; Guedeney A; Delhanty P; Geenen V; Martens H; Muscatelli F; Cohen D; Consoli A; Payoux P; Arnaud C; Salles JP
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28100688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapeutic approaches for Prader-Willi Syndrome.
    Jerome L
    Can J Psychiatry; 1989 Nov; 34(8):845-6. PubMed ID: 2819652
    [No Abstract]   [Full Text] [Related]  

  • 40. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome.
    Stein DJ; Keating J; Zar HJ; Hollander E
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):23-9. PubMed ID: 8148633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.